Technical Analysis for ZSAN - Zosano Pharma Corporation

Grade Last Price % Change Price Change
grade F 1.97 1.55% 0.03
ZSAN closed up 1.55 percent on Friday, September 20, 2019, on 1.43 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ZSAN trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Bollinger Band Squeeze Range Contraction 1.55%
Narrow Range Bar Range Contraction -1.99%
Narrow Range Bar Range Contraction -1.50%
NR7 Range Contraction -1.50%

Older signals for ZSAN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Zosano Pharma Corporation, a clinical stage specialty pharmaceutical company, develops drug formulations for the treatment of various indications. The company delivers formulations through the skin using its proprietary transdermal microneedle patch system. Its lead product candidates comprise Weekly ZP-PTH, a proprietary formulation of parathyroid hormone that has completed a Phase I clinical study for the treatment of severe osteoporosis in women; ZP-Glucagon, a proprietary formulation of glucagon, which has completed a Phase I study for the emergency treatment of severe hypoglycemia; and ZP-Triptan, a proprietary formulation of zolmitriptan that has completed preclinical animal studies for the treatment of migraine. Zosano Pharma Corporation has a strategic partnership and license agreement with Novo Nordisk A/S to develop a microneedle patch product to administer semaglutide for the treatment of type 2 diabetes. The company was founded in 2006 and is headquartered in Fremont, California.
Diabetes Migraine Treatment Of Migraine Stage Specialty Pharmaceutical Emergency Treatment Severe Hypoglycemia Triptans
Is ZSAN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.65
52 Week Low 1.85
Average Volume 287,843
200-Day Moving Average 3.1756
50-Day Moving Average 2.5518
20-Day Moving Average 2.06
10-Day Moving Average 2.013
Average True Range 0.1325
ADX 38.76
+DI 10.6825
-DI 28.88
Chandelier Exit (Long, 3 ATRs ) 2.1125
Chandelier Exit (Short, 3 ATRs ) 2.2475
Upper Bollinger Band 2.186
Lower Bollinger Band 1.934
Percent B (%b) 0.14
BandWidth 12.23301
MACD Line -0.1604
MACD Signal Line -0.1801
MACD Histogram 0.0197
Fundamentals Value
Market Cap 77.27 Million
Num Shares 39.2 Million
EPS -1.28
Price-to-Earnings (P/E) Ratio -1.54
Price-to-Sales 0.00
Price-to-Book 1.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.15
Resistance 3 (R3) 2.13 2.05 2.12
Resistance 2 (R2) 2.05 2.00 2.06 2.11
Resistance 1 (R1) 2.01 1.98 2.03 2.03 2.10
Pivot Point 1.93 1.93 1.94 1.94 1.93
Support 1 (S1) 1.89 1.88 1.91 1.91 1.84
Support 2 (S2) 1.81 1.86 1.82 1.83
Support 3 (S3) 1.77 1.81 1.82
Support 4 (S4) 1.79